Cargando…

Double minute amplification of mutant PDGF receptor α in a mouse glioma model

In primary brain tumors, oncogenes are frequently amplified and maintained on extrachromosomal DNA as double minutes (DM), but the underlying mechanisms remain poorly understood. We have generated a mouse model of malignant glioma based on knock-in of a mutant PDGF receptor α (PDGFRα) that is expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Hongyan, Feng, Rui, Huang, Yong, Tripodi, Joseph, Najfeld, Vesna, Tsankova, Nadejda M., Jahanshahi, Maryam, Olson, Lorin E., Soriano, Philippe, Friedel, Roland H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329559/
https://www.ncbi.nlm.nih.gov/pubmed/25683249
http://dx.doi.org/10.1038/srep08468
_version_ 1782357450300588032
author Zou, Hongyan
Feng, Rui
Huang, Yong
Tripodi, Joseph
Najfeld, Vesna
Tsankova, Nadejda M.
Jahanshahi, Maryam
Olson, Lorin E.
Soriano, Philippe
Friedel, Roland H.
author_facet Zou, Hongyan
Feng, Rui
Huang, Yong
Tripodi, Joseph
Najfeld, Vesna
Tsankova, Nadejda M.
Jahanshahi, Maryam
Olson, Lorin E.
Soriano, Philippe
Friedel, Roland H.
author_sort Zou, Hongyan
collection PubMed
description In primary brain tumors, oncogenes are frequently amplified and maintained on extrachromosomal DNA as double minutes (DM), but the underlying mechanisms remain poorly understood. We have generated a mouse model of malignant glioma based on knock-in of a mutant PDGF receptor α (PDGFRα) that is expressed in oligodendrocyte precursor cells (OPCs) after activation by a Cre recombinase. In the tumor suppressor INK4/Arf(−/−) background, mutant animals frequently developed brain tumors resembling anaplastic human gliomas (WHO grade III). Besides brain tumors, most animals also developed aggressive fibrosarcomas, likely triggered by Cre activation of mutant PDGFRα in fibroblastic cell lineages. Importantly, in the brain tumors and cell lines derived from brain tumor tissues, we identified a high prevalence of DM Pdgfra gene amplification, suggesting its occurrence as an early mutational event contributing to the malignant transformation of OPCs. Amplicons extended beyond the Pdgfra locus and included in some cases neighboring genes Kit and Kdr. Our genetically defined mouse brain tumor model therefore supports OPC as a cell of origin for malignant glioma and offers an example of a defined temporal sequence of mutational events, thus providing an entry point for a mechanistic understanding of DM gene amplification and its functionality in gliomagenesis.
format Online
Article
Text
id pubmed-4329559
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-43295592015-02-23 Double minute amplification of mutant PDGF receptor α in a mouse glioma model Zou, Hongyan Feng, Rui Huang, Yong Tripodi, Joseph Najfeld, Vesna Tsankova, Nadejda M. Jahanshahi, Maryam Olson, Lorin E. Soriano, Philippe Friedel, Roland H. Sci Rep Article In primary brain tumors, oncogenes are frequently amplified and maintained on extrachromosomal DNA as double minutes (DM), but the underlying mechanisms remain poorly understood. We have generated a mouse model of malignant glioma based on knock-in of a mutant PDGF receptor α (PDGFRα) that is expressed in oligodendrocyte precursor cells (OPCs) after activation by a Cre recombinase. In the tumor suppressor INK4/Arf(−/−) background, mutant animals frequently developed brain tumors resembling anaplastic human gliomas (WHO grade III). Besides brain tumors, most animals also developed aggressive fibrosarcomas, likely triggered by Cre activation of mutant PDGFRα in fibroblastic cell lineages. Importantly, in the brain tumors and cell lines derived from brain tumor tissues, we identified a high prevalence of DM Pdgfra gene amplification, suggesting its occurrence as an early mutational event contributing to the malignant transformation of OPCs. Amplicons extended beyond the Pdgfra locus and included in some cases neighboring genes Kit and Kdr. Our genetically defined mouse brain tumor model therefore supports OPC as a cell of origin for malignant glioma and offers an example of a defined temporal sequence of mutational events, thus providing an entry point for a mechanistic understanding of DM gene amplification and its functionality in gliomagenesis. Nature Publishing Group 2015-02-16 /pmc/articles/PMC4329559/ /pubmed/25683249 http://dx.doi.org/10.1038/srep08468 Text en Copyright © 2015, Macmillan Publishers Limited. All rights reserved http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder in order to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Zou, Hongyan
Feng, Rui
Huang, Yong
Tripodi, Joseph
Najfeld, Vesna
Tsankova, Nadejda M.
Jahanshahi, Maryam
Olson, Lorin E.
Soriano, Philippe
Friedel, Roland H.
Double minute amplification of mutant PDGF receptor α in a mouse glioma model
title Double minute amplification of mutant PDGF receptor α in a mouse glioma model
title_full Double minute amplification of mutant PDGF receptor α in a mouse glioma model
title_fullStr Double minute amplification of mutant PDGF receptor α in a mouse glioma model
title_full_unstemmed Double minute amplification of mutant PDGF receptor α in a mouse glioma model
title_short Double minute amplification of mutant PDGF receptor α in a mouse glioma model
title_sort double minute amplification of mutant pdgf receptor α in a mouse glioma model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329559/
https://www.ncbi.nlm.nih.gov/pubmed/25683249
http://dx.doi.org/10.1038/srep08468
work_keys_str_mv AT zouhongyan doubleminuteamplificationofmutantpdgfreceptorainamousegliomamodel
AT fengrui doubleminuteamplificationofmutantpdgfreceptorainamousegliomamodel
AT huangyong doubleminuteamplificationofmutantpdgfreceptorainamousegliomamodel
AT tripodijoseph doubleminuteamplificationofmutantpdgfreceptorainamousegliomamodel
AT najfeldvesna doubleminuteamplificationofmutantpdgfreceptorainamousegliomamodel
AT tsankovanadejdam doubleminuteamplificationofmutantpdgfreceptorainamousegliomamodel
AT jahanshahimaryam doubleminuteamplificationofmutantpdgfreceptorainamousegliomamodel
AT olsonlorine doubleminuteamplificationofmutantpdgfreceptorainamousegliomamodel
AT sorianophilippe doubleminuteamplificationofmutantpdgfreceptorainamousegliomamodel
AT friedelrolandh doubleminuteamplificationofmutantpdgfreceptorainamousegliomamodel